Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2012 | 1 |
2022 | 2 |
2023 | 2 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Genome Med. 2023 Apr 5;15(1):22. doi: 10.1186/s13073-023-01173-8.
Genome Med. 2023.
PMID: 37020259
Free PMC article.
Recurrence of Anti-Semaphorin 3B-Mediated Membranous Nephropathy after Kidney Transplantation.
Fila M, Debiec H, Perrochia H, Djouadi N, Verpont MC, Buob D, Ronco P.
Fila M, et al. Among authors: djouadi n.
J Am Soc Nephrol. 2022 Mar;33(3):503-509. doi: 10.1681/ASN.2021101323. Epub 2022 Jan 11.
J Am Soc Nephrol. 2022.
PMID: 35017170
Free PMC article.
Item in Clipboard
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Milisavljevic B, Gervais A, Bastard P, Asano T, Bizien L, Barzaghi F, Abolhassani H, Tayoun AA, Aiuti A, Darazam IA, Allende LM, Alonso-Arias R, Arias AA, Aytekin G, Bergman P, Bondesan S, Bryceson YT, Bustos IG, Cabrera-Marante O, Carcel S, Carrera P, Casari G, Chaïbi K, Colobran R, Condino-Neto A, Covill LE, Delmonte OM, Zein LE, Flores C, Gregersen PK, Gut M, Haerynck F, Halwani R, Hancerli S, Hammarström L, Hatipoğlu N, Karbuz A, Keles S, Kyheng C, Leon-Lopez R, Franco JL, Mansouri D, Martinez-Picado J, Akcan OM, Migeotte I, Morange PE, Morelle G, Martin-Nalda A, Novelli G, Novelli A, Ozcelik T, Palabiyik F, Pan-Hammarström Q, de Diego RP, Planas-Serra L, Pleguezuelo DE, Prando C, Pujol A, Reyes LF, Rivière JG, Rodriguez-Gallego C, Rojas J, Rovere-Querini P, Schlüter A, Shahrooei M, Sobh A, Soler-Palacin P, Tandjaoui-Lambiotte Y, Tipu I, Tresoldi C, Troya J, van de Beek D, Zatz M, Zawadzki P, Al-Muhsen SZ, Alosaimi MF, Alsohime FM, Baris-Feldman H, Butte MJ, Constantinescu SN, Cooper MA, Dalgard CL, Fellay J, Heath JR, Lau YL, Lifton RP, Maniatis T, Mogensen TH, von Bernuth H, Le…
See abstract for full author list ➔
Matuozzo D, et al.
Genome Med. 2024 Jan 6;16(1):6. doi: 10.1186/s13073-023-01278-0.
Genome Med. 2024.
PMID: 38184654
Free PMC article.
No abstract available.
Item in Clipboard
Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France.
Minary K, Tanne C, Kwon T, Faudeux C, Clave S, Langevin L, Pietrement C, Enoch C, Parmentier C, Mariani-Kurkdjian P, Weill FX, Jones G, Djouadi N, Morin D, Fila M.
Minary K, et al. Among authors: djouadi n.
Arch Pediatr. 2022 Aug;29(6):448-452. doi: 10.1016/j.arcped.2022.05.011. Epub 2022 Jun 3.
Arch Pediatr. 2022.
PMID: 35662540
Item in Clipboard
Use of T1 mapping in cardiac MRI for the follow-up of Fabry disease in a pediatric population.
Werner O, Ichay L, Djouadi N, Vetromile F, Vincenti M, Guillaumont S, Germain DP, Fila M.
Werner O, et al. Among authors: djouadi n.
Mol Genet Metab Rep. 2023 Dec 29;38:101044. doi: 10.1016/j.ymgmr.2023.101044. eCollection 2024 Mar.
Mol Genet Metab Rep. 2023.
PMID: 38234860
Free PMC article.
Item in Clipboard
Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study).
Magaña-Serrano JA, Almahmeed W, Gomez E, Al-Shamiri M, Adgar D, Sosner P, Herpin D; I PREFER Investigators.
Magaña-Serrano JA, et al.
Am J Cardiol. 2011 Nov 1;108(9):1289-96. doi: 10.1016/j.amjcard.2011.06.044.
Am J Cardiol. 2011.
PMID: 22000627
Item in Clipboard
I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
Bobrie G; I-ADD Study Investigators.
Bobrie G, et al.
Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30.
Clin Ther. 2012.
PMID: 22853847
Clinical Trial.
Item in Clipboard
Cite
Cite